Dossier
Quicksilver Scientific
Coverage of Quicksilver Scientific in the Nexus archive.
- RFK Jr.'s peptide push could become next wellness boom
RFK Jr. advocates for loosening federal restrictions on peptides, potentially boosting telehealth companies, compounding pharmacies, and longevity clinics. The FDA will review peptide regulations in July, while experts debate their efficacy and safety, with market projections reaching $180 billion in five years.